HER2 positivity in metastatic upper gastrointestinal tumours in a large multi-centre UK cohort identifies similar positivity rates but different trends than previously reported and suggests new potential avenues for HER2 therapies

Category Primary study
JournalGastroenterology
Year 2013
This article has no abstract
Epistemonikos ID: b57f03005d3cd0435868e11f1740786efa4872ce
First added on: Feb 05, 2025